Home R&D Page 3

R&D

Medicines Discovery Catapult and ZEISS join forces to improve drug discovery
Featured

Medicines Discovery Catapult and ZEISS join forces to improve drug discovery

Tess Egginton -
0
Relmada Therapeutics receives FDA Fast Track designation for major depressive disorder treatment
Featured

Relmada Therapeutics receives FDA Fast Track designation for major depressive disorder treatment

Tess Egginton -
0
Poseida Therapeutics to collaborate with Roche to develop allogeneic CAR-T cell therapies for hematologic malignancies
Featured

Poseida Therapeutics to collaborate with Roche to develop allogeneic CAR-T cell therapies for hematologic malignancies

Tess Egginton -
0
QUANTRO Therapeutics collaborates with Boehringer Ingelheim to develop drug candidates interfering with transcriptional regulators
Featured

QUANTRO Therapeutics collaborates with Boehringer Ingelheim to develop drug candidates interfering with transcriptional regulators

Tess Egginton -
0
University of Birmingham signs licensing deal with world’s largest COVID-19 test provider to commercialise novel testing method
Featured

University of Birmingham signs licensing deal with world’s largest COVID-19 test provider to commercialise novel testing method

Tess Egginton -
0
NIH and GreenLight Biosciences to collaborate on COVID-19 vaccine development for new variants
Featured

NIH and GreenLight Biosciences to collaborate on COVID-19 vaccine development for new variants

Tess Egginton -
0
Ipsen and Marengo Therapeutics announce strategic partnership to advance two precision immuno-oncology candidates into the clinic
Featured

Ipsen and Marengo Therapeutics announce strategic partnership to advance two precision immuno-oncology candidates into the clinic

Tess Egginton -
0
European Orphan Medicinal Product Designation granted to Sangamo Therapeutics’ investigational CAR-Treg cell therapy TX200 for solid organ transplantation
Featured

European Orphan Medicinal Product Designation granted to Sangamo Therapeutics’ investigational CAR-Treg cell therapy TX200 for solid organ transplantation

Tess Egginton -
0
Karyopharm granted new regulatory designations for eltanexor for the treatment of myelodysplastic syndromes
Featured

Karyopharm granted new regulatory designations for eltanexor for the treatment of myelodysplastic syndromes

Tess Egginton -
0
Otsuka receives positive CHMP opinion for Lupkynis (voclosporin) for the treatment of active lupus nephritis
Featured

Otsuka receives positive CHMP opinion for Lupkynis (voclosporin) for the treatment of active lupus nephritis

Tess Egginton -
0
1234...16Page 3 of 16

© 2021 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks